chunk_id int64 1M 11.9M | document stringlengths 3 4.98k | embedding listlengths 384 384 |
|---|---|---|
10,008,703 | Electrophysiologic consequences of experimental acute ischemia superimposed on healed myocardial infarction in cats. | [
0.07080654054880142,
-0.029678024351596832,
0.09147672355175018,
0.10422883182764053,
0.04309144616127014,
-0.0157131589949131,
0.004900292959064245,
0.06510808318853378,
0.01737023890018463,
0.02764972858130932,
-0.0300299022346735,
-0.006165201775729656,
-0.03192593902349472,
0.056309685... |
10,008,704 | Failure of nifedipine therapy to reduce myocardial infarct size in the baboon. | [
-0.016413528472185135,
-0.017441116273403168,
-0.03459929674863815,
0.014669002965092659,
-0.007912334986031055,
-0.03351727873086929,
-0.0327090248465538,
0.1347058117389679,
0.03176955506205559,
-0.05748763307929039,
-0.07823002338409424,
0.0028709941543638706,
-0.03240572661161423,
0.07... |
10,008,705 | The value of nifedipine in reducing the ultimate size of an infarct associated with a period of coronary occlusion followed by reperfusion was assessed. Eight baboons were administered a bolus dose of nifedipine, 5 micrograms/kg intravenously, and then a maintenance dose of 30 micrograms/kg per hour was begun 1 hour be... | [
0.022757723927497864,
-0.01766238920390606,
-0.035689450800418854,
0.030588218942284584,
-0.021466314792633057,
-0.031676407903432846,
-0.02189563401043415,
0.1609959751367569,
0.09152524173259735,
-0.0617019385099411,
-0.04907047748565674,
0.011250632815063,
-0.0027019602712243795,
0.0562... |
10,008,706 | Pulsed Doppler echocardiography in the diagnosis and estimation of severity of aortic insufficiency. | [
0.02134479209780693,
-0.03208576887845993,
-0.026522580534219742,
0.029518160969018936,
0.05555010586977005,
-0.07334832102060318,
-0.06266912817955017,
0.014803912490606308,
-0.0016818973235785961,
-0.10037852078676224,
-0.028365250676870346,
0.01849541626870632,
0.033080048859119415,
-0.... |
10,008,707 | Detection and estimation of the degree of chronic aortic insufficiency with pulsed Doppler echocardiography was attempted in 27 patients documented to have aortic insufficiency on aortography. Twenty-five patients had associated aortic stenosis or mitral valve disease, or both. A disturbed diastolic flow within the lef... | [
0.05193868279457092,
-0.0431758351624012,
-0.02521274983882904,
0.01920165866613388,
0.042708639055490494,
-0.053038809448480606,
-0.05852128937840462,
0.014867011457681656,
0.01136768888682127,
-0.11614950746297836,
-0.03266433998942375,
0.03056718409061432,
0.06901969015598297,
-0.037596... |
10,008,708 | Noninvasive His Bundle electrogram: value of three vector lead recordings. | [
0.021955939009785652,
-0.002884278306737542,
-0.030571479350328445,
-0.049628470093011856,
-0.010429710149765015,
0.059312477707862854,
0.0073538003489375114,
0.0029772347770631313,
-0.00948020163923502,
-0.026342537254095078,
0.10182790458202362,
-0.08806639909744263,
-0.007812907919287682,... |
10,008,709 | Studies were conducted in 45 patients to determine whether the reliability of the measurement of the His bundle potential from the body surface was increased by signal averaging of three simultaneously recorded electrocardiographic potentials from horizontal (X), frontal (Y) and sagittial (Z) axes as opposed to recordi... | [
-0.0014599041314795613,
0.02024155482649803,
-0.04717773571610451,
-0.03666647523641586,
0.004355376586318016,
0.01432573702186346,
-0.02002483606338501,
0.08171721547842026,
-0.010507582686841488,
-0.048317745327949524,
0.06217893958091736,
-0.05197795853018761,
0.04376407340168953,
0.053... |
10,008,710 | A new technique for noninvasive evaluation of femoral arterial and venous anatomy before and after percutaneous cardiac catheterization in children and infants. | [
0.034186217933893204,
0.06621825695037842,
-0.08667372167110443,
-0.015321418642997742,
-0.033131733536720276,
-0.0255691260099411,
-0.053086306899785995,
0.029498523101210594,
0.03167076036334038,
-0.005402395036071539,
-0.02054809406399727,
0.06048906594514847,
-0.023025158792734146,
0.0... |
10,008,711 | A new ultrasonic method was applied to image the femoral artery and vein in children for evaluation of short- and long-term effects of cardiac catheterization with femoral percutaneous cannulation. Sixty-six children and infants (aged 5 days to 20 years) were studied with a 9 megahertz electronically focused real time ... | [
0.0584469698369503,
0.012879296205937862,
-0.0724622905254364,
-0.010028380900621414,
0.005264227278530598,
-0.05545177683234215,
-0.029024729505181313,
0.07739005982875824,
-0.02955937385559082,
-0.009065636433660984,
0.002168930135667324,
0.06713514029979706,
0.042688339948654175,
0.0676... |
10,008,712 | Growth and development of ventricular walls in complete transposition of the great arteries with intact septum (simple transposition). | [
0.06186169013381004,
-0.034240808337926865,
-0.00008493667701259255,
-0.05320494621992111,
-0.08958350867033005,
-0.030632928013801575,
-0.11775597184896469,
-0.017450351268053055,
0.01013580709695816,
-0.007434028200805187,
0.044541794806718826,
-0.008911827579140663,
-0.015592296607792377,... |
10,008,713 | Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy. | [
0.07548832148313522,
-0.040495991706848145,
-0.01592356152832508,
0.008939463645219803,
-0.09960980713367462,
-0.03886645287275314,
-0.0161451306194067,
0.08790355920791626,
0.08099278807640076,
-0.059535764157772064,
0.03243015706539154,
0.017740951851010323,
-0.054929036647081375,
0.0409... |
10,008,714 | The effects of different oral doses of isosorbide dinitrate administered acutely and four times daily during sustained therapy were studied in 12 patients with angina pectoris. After administration of 30, 60 and 120 mg of isosorbide dinitrate, the average plasma concentrations were higher and the area under the plasma ... | [
0.06133197247982025,
-0.023381181061267853,
-0.013257449492812157,
-0.002483643125742674,
-0.07070223987102509,
-0.006196335423737764,
-0.017687037587165833,
0.09649202972650528,
0.04861309379339218,
-0.07597533613443375,
0.010050583630800247,
0.04359922558069229,
-0.01230941154062748,
0.0... |
10,008,715 | Effects of sulfinpyrazone on early graft closure after myocardial revascularization. | [
0.002970414701849222,
-0.030175860971212387,
0.01822769083082676,
0.03438910096883774,
-0.014143893495202065,
-0.011780638247728348,
0.02797161601483822,
0.09874957799911499,
0.04385438933968544,
-0.03713865205645561,
0.011309860274195671,
0.16005299985408783,
-0.036674849689006805,
0.0919... |
10,008,716 | The effect of sulfinpyrazone on the incidence of early postoperative closure of saphenous vein bypass grafts was compared with placebo in a prospective randomized study of 255 eligible patients. Treatment with sulfinpyrazone (800 mg/day) was started 24 hours after operation in 130 patients; 125 patients received placeb... | [
-0.010387497022747993,
-0.04343249648809433,
-0.04582071676850319,
-0.016821928322315216,
-0.06643363833427429,
-0.00998924020677805,
0.020098015666007996,
0.15561892092227936,
0.037298496812582016,
-0.03787672147154808,
0.02432977221906185,
0.13407687842845917,
-0.023721488192677498,
0.04... |
10,008,717 | M mode and cross-sectional echocardiographic recognition of fibrosis and calcification of the mitral valve chordae and left ventricular papillary muscles. | [
-0.0015904553001746535,
-0.04631473869085312,
-0.042516596615314484,
-0.05960678309202194,
-0.03897646442055702,
0.05828044191002846,
-0.04246506467461586,
0.02362726256251335,
0.025967229157686234,
-0.03425559401512146,
0.11426464468240738,
-0.029830098152160645,
-0.013291326351463795,
0.... |
10,008,718 | The echocardiographic appearance of fibrotic thickening and calcification of mitral valve chordae tendineae and left ventricular papillary muscles in 17 patients is described. Pathologic proof of excessive fibrosis or calcification was obtained in five patients. In a sixth patient, calcium was demonstrated on angiograp... | [
-0.02077746018767357,
-0.05127403885126114,
-0.039932698011398315,
-0.032945092767477036,
-0.03930363431572914,
0.014416498132050037,
-0.042077552527189255,
0.028624866157770157,
0.05106981098651886,
-0.02388913929462433,
0.11214600503444672,
-0.013887912034988403,
0.042659465223550797,
0.... |
10,008,719 | Severe aortic regurgitation from systemic hypertension (without aortic dissection) requiring aortic valve replacement: analysis of four patients. | [
0.006812647916376591,
0.03729118034243584,
-0.002641524188220501,
0.009512020274996758,
-0.007119030226022005,
-0.03711964935064316,
-0.08156313747167587,
-0.05741995945572853,
0.005501911975443363,
-0.0586322657763958,
-0.014847569167613983,
0.005393411032855511,
0.0076287598349153996,
-0... |
10,008,720 | Clinical and morphologic observations are described in four patients who had severe aortic regurgitation from severe systemic hypertension unassociated with aortic dissection; each patient underwent aortic valve replacement. Although aortic regurgitation of minimal or mild degree is well recognized to occur in patients... | [
0.04870996251702309,
0.007486455608159304,
0.012532908469438553,
0.014899030327796936,
0.0056006330996751785,
-0.07511745393276215,
-0.07330650091171265,
-0.023519836366176605,
0.02005758509039879,
-0.07705363631248474,
0.018044183030724525,
0.012056461535394192,
0.020283494144678116,
-0.0... |
10,008,721 | Digoxin--quinidine interaction. | [
-0.10541325062513351,
0.0004134634218644351,
-0.032132960855960846,
-0.031095391139388084,
0.0258039403706789,
-0.026623105630278587,
0.029325101524591446,
0.06571654230356216,
0.01141755934804678,
0.0006530233658850193,
-0.014361678622663021,
-0.041498083621263504,
-0.034480851143598557,
... |
10,008,722 | Blood oxygen measurements in assessment of intracardiac left to right shunts. | [
-0.014136537909507751,
0.012977002188563347,
-0.025794677436351776,
0.06746259331703186,
-0.033468980342149734,
-0.05994807183742523,
-0.017750753089785576,
0.0025316565297544003,
0.022153818979859352,
-0.053607434034347534,
0.016389600932598114,
0.010800652205944061,
-0.00857847835868597,
... |
10,008,723 | Symposium on cardiovascular disease and calcium antagonists. | [
-0.02152791991829872,
-0.00595472427085042,
-0.010567937977612019,
0.08106229454278946,
-0.04570502042770386,
-0.009108773432672024,
-0.08333476632833481,
0.06379493325948715,
0.03693287819623947,
0.03617909178137779,
-0.017715156078338623,
-0.008490940555930138,
-0.0028945724479854107,
0.... |
10,008,724 | Symposium on Cardiovascular Disease and Calcium Antagonists. Introduction. | [
-0.011019289493560791,
-0.004219519440084696,
-0.009828765876591206,
0.08092859387397766,
-0.0503699965775013,
-0.003207731992006302,
-0.08178825676441193,
0.06706909835338593,
0.037562958896160126,
0.037713028490543365,
-0.010434303432703018,
-0.004584739916026592,
-0.0004925422836095095,
... |
10,008,725 | Pharmacokinetics of diltiazem in selected animal species and human beings. | [
0.13908712565898895,
-0.02295108139514923,
-0.01357115339487791,
0.06003258377313614,
-0.08400990813970566,
0.0030369514133781195,
-0.004434013739228249,
0.1296503096818924,
0.029338302090764046,
0.039217330515384674,
0.04005635157227516,
-0.030024096369743347,
-0.011070886626839638,
0.082... |
10,008,726 | The absorption, distribution and elimination of diltiazem hydrochloride in rodent and canine species are reviewed. The drug is well absorbed but undergoes first pass metabolism after oral administration. Diltiazem is extensively distributed, and 52 to 81 percent is bound to serum protein, depending on the species studi... | [
0.10281817615032196,
-0.014565955847501755,
0.01722906157374382,
0.03705243766307831,
-0.07270816713571548,
-0.051946647465229034,
-0.011718557216227055,
0.1049036756157875,
0.0184073094278574,
-0.0338381864130497,
-0.01357648242264986,
0.04920177906751633,
0.036129023879766464,
0.09381639... |
10,008,727 | The pharmacokinetics of diltiazem in healthy American men. | [
0.1487698256969452,
-0.01760554499924183,
-0.03380677103996277,
0.05444663017988205,
-0.07838308066129684,
-0.010927208699285984,
0.019694289192557335,
0.11343996226787567,
-0.017012864351272583,
-0.005830895621329546,
0.02026715688407421,
0.012949885800480843,
-0.01115986704826355,
0.0462... |
10,008,728 | Plasma diltiazem concentration was determined for 24 hours after oral administration of 30, 60, 90 and 120 mg (sustained release tablets) in healthy adult white men. The plasma concentration was too low after the 30 mg dose to calculate pharmacokinetic variables. After administration of 60 mg (n = 12), 90 mg (n = 10), ... | [
0.11867789924144745,
-0.0002249644312541932,
-0.021149879321455956,
-0.014318489469587803,
-0.10263939946889877,
-0.02054157294332981,
0.011679903604090214,
0.20403900742530823,
0.04636508226394653,
0.005361674819141626,
-0.02229061722755432,
-0.021789852529764175,
0.0008818178903311491,
0... |
10,008,729 | Diltiazem for long-term therapy of coronary arterial spasm. | [
0.09820741415023804,
0.03850113973021507,
0.03302788361907005,
0.04882156103849411,
-0.07492566853761673,
-0.06564244627952576,
0.0006767099257558584,
0.07918010652065277,
0.03932598605751991,
-0.04989657551050186,
0.018191246315836906,
0.01672133058309555,
-0.03550396114587784,
0.09408085... |
10,008,730 | The first 36 patients with coronary arterial spasm treated with diltiazem and followed up at the Stanford University Coronary Artery Spasm Clinic for 6 months or longer are described. There were 13 men and 23 women with a mean age of 50.2 years; the mean duration of angina was 36.1 months. All patients had angina at re... | [
0.10386238992214203,
-0.017796538770198822,
0.02844487689435482,
0.10505113750696182,
-0.09298805147409439,
-0.03996385633945465,
-0.003915955778211355,
0.08907870948314667,
0.05346924439072609,
-0.06060987338423729,
-0.008150332607328892,
0.04526573792099953,
-0.03967078775167465,
0.10154... |
10,008,731 | Divergent effects of diltiazem in patients with exertional angina. | [
0.1604495793581009,
-0.010935918428003788,
0.021518370136618614,
0.07537566870450974,
0.015509568154811859,
-0.044163938611745834,
-0.052314408123493195,
0.0819995179772377,
0.019699543714523315,
-0.042839355766773224,
0.052198562771081924,
0.03732297196984291,
-0.011343364603817463,
0.072... |
10,008,732 | The effects of calcium channel blocking agents on cardiovascular function. | [
-0.009063968434929848,
-0.0326676070690155,
0.06681493669748306,
0.028401317074894905,
-0.04611678048968315,
0.002711686072871089,
-0.04855019226670265,
0.008629162795841694,
0.04860459640622139,
0.018566353246569633,
0.02371296100318432,
0.03096066229045391,
-0.0072981975972652435,
0.0382... |
10,008,733 | The hemodynamic effects of calcium blocking agents are a composite of the various direct and indirect cardiac and peripheral vascular actions of these drugs on the individual determinants of left ventricular pump function. Calcium antagonists have been shown to have a direct negative inotropic effect, a direct negative... | [
-0.000816191139165312,
-0.027890857309103012,
0.03294476866722107,
0.06676232069730759,
0.007020916789770126,
-0.0204337015748024,
-0.030616847798228264,
0.030158890411257744,
0.09487404674291611,
0.015078744851052761,
0.03480366989970207,
-0.024479148909449577,
0.020467571914196014,
0.039... |
10,008,734 | Hemodynamic and gas exchange effects of intravenous diltiazem in patients with pulmonary hypertension. | [
0.08018730580806732,
0.041791412979364395,
-0.012407340109348297,
0.011374441906809807,
-0.02399509958922863,
-0.040003348141908646,
-0.043632782995700836,
0.10119267553091049,
0.030362224206328392,
-0.030935076996684074,
0.053531572222709656,
-0.012260736897587776,
-0.005362413823604584,
... |
10,008,735 | Electrophysiologic effects of diltiazem in canine myocardium, with special reference to conduction delay during ischemia. | [
0.08215335011482239,
-0.01610945537686348,
0.07723430544137955,
0.10191158205270767,
-0.03065728396177292,
-0.04062480106949806,
0.005729442462325096,
0.07405216991901398,
0.057945169508457184,
0.022654540836811066,
0.05219344049692154,
-0.034569378942251205,
0.037600740790367126,
0.107603... |
10,008,736 | Comparative electrophysiologic and coronary hemodynamic effects of diltiazem, nisoldipine and verapamil on myocardial tissue. | [
0.08951590210199356,
0.0114270756021142,
0.04051303118467331,
0.10859639942646027,
0.021453119814395905,
-0.07192372530698776,
-0.044929854571819305,
0.07408114522695541,
0.08280906826257706,
-0.04373147711157799,
-0.004713702481240034,
-0.029363026842474937,
-0.025579316541552544,
0.08675... |
10,008,737 | Electrophysiologic effects of diltiazem hydrochloride on supraventricular tachycardia. | [
0.08102139085531235,
-0.020649047568440437,
0.01417007390409708,
0.059933386743068695,
0.028428886085748672,
-0.03647403046488762,
0.009680449031293392,
0.0457955040037632,
0.0153124975040555,
-0.05495337396860123,
0.052317094057798386,
-0.07991918921470642,
-0.019680244848132133,
0.043573... |
10,008,738 | The effects of intravenous diltiazem hydrochloride (0.25 mg/kg body weight) were studied in eight patients with nine episodes of supraventricular tachycardia. Five episodes of tachycardia were due to atrioventricular (A-V) nodal reentry (group A), two were due to retrograde utilization of a concealed A-V accessory path... | [
0.0671844482421875,
-0.03525223210453987,
0.03134525939822197,
0.06969175487756729,
0.01749214343726635,
-0.009731139056384563,
-0.04803656414151192,
0.031536102294921875,
0.04210218787193298,
-0.06190774589776993,
0.07797180116176605,
-0.050088461488485336,
0.029033232480287552,
0.0452581... |
10,008,739 | Dedifferentiation of iris epithelium during lens regeneration in newt larvae. | [
-0.021890876814723015,
-0.04938622564077377,
0.04975743591785431,
-0.08388043940067291,
-0.0010943087982013822,
-0.05313918739557266,
0.10612089931964874,
-0.05746918544173241,
-0.03650864213705063,
0.10379212349653244,
0.06152678281068802,
-0.02376306802034378,
-0.06217321753501892,
0.031... |
10,008,740 | Early stages in lens regeneration from the pigmented epithelium of the dorsal iris were studied in larval Notophthalmus viridescens by means of transmission electron microscopy. Normal iris epithelium is composed of two layers of low cuboidal cells. packed with melanosomes and surrounded by a basal lamina. Scattered de... | [
-0.02564234472811222,
-0.04247843101620674,
0.02444993518292904,
-0.05097665265202522,
0.04677755385637283,
-0.027868010103702545,
0.08266852796077728,
-0.019160794094204903,
-0.0010177920339629054,
0.09160957485437393,
0.06928450614213943,
-0.083448126912117,
-0.01580924354493618,
0.00160... |
10,008,741 | Lens regeneration from the pupillary margin of the eyecup in newt embryos. | [
-0.019392868503928185,
-0.05593131482601166,
-0.012564294971525669,
-0.07538783550262451,
-0.0162830613553524,
-0.01328969094902277,
0.10406378656625748,
-0.03312984108924866,
-0.0584600605070591,
0.11594882607460022,
0.038353025913238525,
-0.016726255416870117,
-0.11307664215564728,
0.071... |
10,008,742 | Early stages in lens regeneration from the dorsal margin of the pupil, following removal of the young lens from the embryonic eyecup, were studied with transmission electron microscopy in Notophthalmus viridescens. At the stage of operation, the eyecup cells have an undifferentiated, embryonic appearance with numerous ... | [
-0.016492413356900215,
-0.03907068073749542,
-0.024229800328612328,
-0.03072194941341877,
0.008101819083094597,
-0.02172790840268135,
0.06391843408346176,
-0.009241272695362568,
-0.0009982131887227297,
0.10682875663042068,
0.08563306927680969,
-0.10321082919836044,
-0.04951044172048569,
-0... |
10,008,743 | Further observations on the Sertoli cell junctions of the mouse testis after metal contract freeze-fracture, and comparisons with cellular junctions of other epithelial cells. | [
0.006873873062431812,
-0.04094856604933739,
0.00014543627912644297,
0.03761375695466995,
-0.04256569966673851,
-0.01610676199197769,
0.046148382127285004,
0.042986441403627396,
0.04137297719717026,
0.040880877524614334,
-0.02175520546734333,
0.0524483248591423,
-0.03979109600186348,
0.0434... |
10,008,744 | Using a metal contact freezing methods, the junctional complexes of Sertoli cells and other epithelial cells (intestine, liver, and epididymis) in the mouse were studied by freeze-fracture in unfixed and in aldehyde-fixed specimens. The tight junctions of the Sertoli cells without fixation consists of discrete rows of ... | [
0.016127249225974083,
-0.06632961332798004,
0.03002171404659748,
0.017486900091171265,
-0.04404512047767639,
0.013142647221684456,
0.04426180571317673,
0.05346683785319328,
0.036146145313978195,
0.02463693358004093,
-0.026817524805665016,
0.00993265863507986,
-0.035777606070041656,
-0.0219... |
10,008,745 | Degeneration of mouse digital corpuscles. | [
-0.026612428948283195,
-0.07441119104623795,
0.06809607148170471,
-0.07685985416173935,
-0.03877183794975281,
-0.05603255704045296,
0.06474431604146957,
0.025097964331507683,
0.004464323632419109,
0.09841130673885345,
0.04723058268427849,
0.02486071176826954,
-0.05850392207503319,
0.059972... |
10,008,746 | The sequential changes of the morphology and the histochemically demonstrated, nonspecific cholinesterase (ChE) activity of the denervated digital corpuscle (Meissner corpuscle) of the mouse were observed by light and electron microscopy for 6 months after transection of the sciatic nerve. A fragment of the sciatic ner... | [
-0.042235542088747025,
-0.10097981244325638,
0.05018402263522148,
-0.0009643951780162752,
-0.050801049917936325,
-0.04784492403268814,
-0.0030739542562514544,
0.09711157530546188,
0.011244742199778557,
0.08543562889099121,
0.08557251840829849,
0.04417577385902405,
-0.02426433376967907,
0.0... |
10,008,747 | Regeneration of mouse digital corpuscles. | [
-0.046814851462841034,
-0.09546149522066116,
0.0486161932349205,
-0.09028464555740356,
-0.060526151210069656,
-0.016262955963611603,
0.08018264919519424,
-0.020415209233760834,
0.002217800822108984,
0.09187479317188263,
0.04438706114888191,
0.05064762756228447,
-0.08635172247886658,
0.0489... |
10,008,748 | Changes in morphology and nonspecific cholinesterase (ChE) activity during the reinnervation of digital corpuscles of mouse toe pads after transection of the sciatic nerve were examined by light and electron microscopy. Reinnervation occurred about 30 days after nerve section. A small-diameter axon was present near the... | [
-0.02072850987315178,
-0.1565636843442917,
0.05300118401646614,
0.006850270088762045,
-0.07833100855350494,
-0.0280690249055624,
0.004151549655944109,
0.08079476654529572,
0.018199453130364418,
0.05865010619163513,
0.11433401703834534,
0.05263041704893112,
-0.03161949664354324,
0.064771689... |
10,008,749 | An epidemiologist views senile dementia--facts and fragments. | [
0.05481933057308197,
-0.035677917301654816,
-0.07416790723800659,
0.04857160523533821,
0.010182573460042477,
0.008574428036808968,
0.06773090362548828,
0.023653710260987282,
-0.13025043904781342,
0.017185376957058907,
0.047148287296295166,
0.07201091200113297,
-0.008896377868950367,
0.0416... |
10,008,750 | Prevalence of hepatitis A antibodies in a normal population and some selected groups of patients in Norway. | [
0.045604486018419266,
0.015736602246761322,
-0.031025303527712822,
-0.0830511823296547,
0.0464523546397686,
0.0341922864317894,
-0.047555118799209595,
0.10670585930347443,
-0.0042103929445147514,
0.038145761936903,
0.027820946648716927,
-0.02635144628584385,
-0.049510400742292404,
0.005841... |
10,008,751 | The prevalence of hepatitis A virus antibodies was tested by radioimmunoassay in Norway in healthy blood donors, in patients without clinical signs of liver diseases and in two selected groups of patients. The presence of hepatitis A antibodies was highly age-dependent in 625 normal persons. A major reduction occurred ... | [
0.043330900371074677,
0.01754717342555523,
-0.0798434242606163,
-0.04284397140145302,
-0.010579082183539867,
0.08733101189136505,
0.04878602921962738,
0.10339260846376419,
-0.045876629650592804,
0.03287215903401375,
0.03146608918905258,
0.0064216963946819305,
0.03194355219602585,
0.0458024... |
10,008,752 | Assessment of plasma total cholesterol as a test to detect elevated low density (beta) lipoprotein cholesterol levels (type IIa hyperlipoproteinemia) in young subjects from a population-based sample. | [
0.024619190022349358,
-0.054617173969745636,
-0.027799712494015694,
0.007813124917447567,
-0.01715821772813797,
-0.03151019290089607,
-0.01764095388352871,
0.057704124599695206,
-0.020749850198626518,
-0.06197773665189743,
0.01200649794191122,
-0.020898092538118362,
-0.0609595961868763,
0.... |
10,008,753 | The measurement of plasma total cholesterol as a screening test for an increased plasma level of low density lipoprotein cholesterol (greater than age- and sex-adjusted 95th percentile) with a normal plasma triglyceride level (type IIa hyperlipoproteinemia) was assessed in 1325 young subjects, aged 6 to 19 years, from ... | [
0.005575037095695734,
-0.011506050825119019,
-0.04764590784907341,
0.0009920182637870312,
-0.046135347336530685,
-0.053888950496912,
-0.036023762077093124,
0.04740739241242409,
0.0016747865593060851,
-0.04571915417909622,
0.023739611729979515,
-0.018126988783478737,
-0.06335413455963135,
-... |
10,008,754 | The sex differential in mortality rates: demographic and behavioral factors. | [
0.10902811586856842,
0.01615588553249836,
-0.028022853657603264,
0.07829099893569946,
0.03350242227315903,
0.0447959266602993,
-0.069212406873703,
-0.026797818019986153,
-0.07532058656215668,
0.05104780197143555,
0.022126348689198494,
-0.03830141946673393,
0.0007908364641480148,
0.00639832... |
10,008,755 | By using the 1965 Human Population Laboratory Survey of a random sample of 6928 adults in Alameda County, California, and a nine-year follow-up, mortality risk is examined by sex, while simultaneously controlling for 16 demographic and behavioral risk factors by a multiple logistic analysis. Risk factors include age, r... | [
0.08611437678337097,
0.03658633679151535,
-0.039378728717565536,
0.09213831275701523,
-0.016235098242759705,
0.07210147380828857,
-0.05875294283032417,
-0.031198881566524506,
-0.06716129928827286,
0.0009964022319763899,
0.032053545117378235,
-0.07890740782022476,
0.0012837972026318312,
-0.... |
10,008,756 | Predicting coronary heart disease in siblings--a multivariate assessment: the Framingham Heart Study. | [
0.05825628340244293,
0.04923142492771149,
-0.02814926765859127,
0.05196443945169449,
0.04203653708100319,
0.015239166095852852,
-0.10857569426298141,
-0.026599375531077385,
0.009765403345227242,
-0.06981983780860901,
0.03322180360555649,
-0.04088696837425232,
-0.022050485014915466,
0.01890... |
10,008,757 | The incidence of clinically recognized coronary heart disease and its relation to risk factors have been studied for 596 sibships in the Framingham Heart Study cohort. Only the 186 pairs of brothers were considered in the multivariate analysis, since the rate of coronary heart disease in women is low. Multiple logistic... | [
-0.003170153358951211,
0.02978614531457424,
-0.08730993419885635,
0.03381861746311188,
0.029685670509934425,
-0.007883042097091675,
-0.0914752334356308,
0.03470774367451668,
0.01594482734799385,
-0.10106281191110611,
0.013767738826572895,
-0.019251495599746704,
0.0029610509518533945,
-0.02... |
10,008,758 | Comparison of self-reported and measured height and weight. | [
0.05401104688644409,
0.08559639006853104,
-0.01256916206330061,
0.09855945408344269,
-0.05099162459373474,
-0.008707629516720772,
0.03462645784020424,
0.14979621767997742,
-0.0403207391500473,
-0.022073039785027504,
0.04323212057352066,
-0.0861198902130127,
0.012431904673576355,
0.05104587... |
10,008,759 | Screening data from the Hypertension Detection and Follow-up Program in Minneapolis, MN, 1973-1974, provided an opportunity to evaluate the accuracy of self-report of height and weight. It was found that both were reported, on the average, with small but systematic errors. Large errors were found in certain population ... | [
0.022885823622345924,
0.10610802471637726,
0.03725353628396988,
0.10721369087696075,
0.03273725509643555,
-0.037469532340765,
-0.002612098352983594,
0.03608997166156769,
-0.09888946264982224,
-0.011881953105330467,
0.0429101400077343,
-0.013388877734541893,
0.040546026080846786,
-0.0112192... |
10,008,760 | Clinical characteristics and cigarette smoking in relation to prognosis of angina pectoris in Framingham. | [
0.0896662101149559,
0.0680295005440712,
-0.03183912858366966,
-0.0072197080589830875,
0.03541057929396629,
0.012968180701136589,
-0.061165399849414825,
0.027757130563259125,
0.018081016838550568,
-0.02502790093421936,
-0.013995383866131306,
-0.014152188785374165,
-0.05416690558195114,
-0.0... |
10,008,761 | A long-term follow-up study of 130 Framingham, Massachusetts, men with newly diagnosed uncomplicated angina pectoris was undertaken in an attempt to identify medical and personal characteristics which could predict the likelihood of a future coronary event. Analyses indicated that, among the baseline characteristics, s... | [
0.04770033061504364,
0.06583666801452637,
0.016968125477433205,
0.03560584783554077,
0.05986557900905609,
0.041506748646497726,
-0.06507489085197449,
0.0031535516027361155,
0.03442247211933136,
-0.05212147533893585,
0.016314079985022545,
0.026282820850610733,
-0.05345061421394348,
-0.03011... |
10,008,762 | Mortality in women treated for hyperthyroidism. | [
0.02520761266350746,
0.022237321361899376,
0.015753094106912613,
-0.06024889275431633,
0.004664260894060135,
-0.019694223999977112,
-0.05904518440365791,
0.002581017790362239,
-0.06647440791130066,
0.021171044558286667,
0.0021410577464848757,
-0.0016790293157100677,
0.026814550161361694,
-... |
10,008,763 | To evaluate the late effects of exposure to radioiodine (131I), a retrospective cohort study was conducted of women treated for hyperthyroidism at the Mayo Clinic, Rochester, Minnesota, from 1946 through 1964. Cause of death was determined in 1005 women treated with 131I and in 2141 women surgically treated. No increas... | [
0.06418251991271973,
0.013850894756615162,
-0.025283319875597954,
-0.0477684922516346,
0.03246524557471275,
-0.015081771649420261,
0.0008292763377539814,
0.06989794969558716,
-0.07019879668951035,
0.031060446053743362,
0.012059332802891731,
-0.049662671983242035,
0.07232226431369781,
-0.02... |
10,008,764 | Frequency of urolithiasis in a prepaid medical care program. | [
0.08817635476589203,
-0.012365996837615967,
-0.005216220859438181,
-0.00814877264201641,
-0.13761551678180695,
-0.022910350933670998,
0.0016689286567270756,
0.06705985963344574,
0.04814188927412033,
-0.07000716030597687,
-0.0065846857614815235,
0.05643594637513161,
0.02952941693365574,
0.0... |
10,008,765 | The rate of occurrence of stones of the urinary tract was assessed in a large population served by the Northern California Kaiser Foundation Health Plan. The study involved three separate groups. First, data were obtained by questionnaire from approximately 175,000 adults who took a multiphasic health checkup in the pe... | [
0.09324764460325241,
0.02166210114955902,
0.03553801774978638,
0.05337129160761833,
-0.1237579956650734,
-0.012507067061960697,
-0.07670874893665314,
0.03179425746202469,
0.023593541234731674,
-0.03371576964855194,
0.017850127071142197,
-0.012779967859387398,
0.002889465307816863,
0.047294... |
10,008,766 | Rabies in Ethiopia. | [
0.03678471967577934,
0.10599300265312195,
-0.05574161559343338,
0.0646241083741188,
-0.007798997685313225,
-0.016455333679914474,
-0.020228587090969086,
0.01659296080470085,
-0.015894580632448196,
0.07837619632482529,
0.01769183576107025,
-0.03056526556611061,
-0.0010201032273471355,
0.029... |
10,008,767 | Rabies is one of the most severe infectious diseases in Ethiopia, with many cases of the disease diagnosed in various parts of the country. The dog is the species most responsible for human exposure, with over 98% of the human cases and vaccinations due to the bite of rabid or suspected rabid dogs. Most of the treatmen... | [
0.06224183738231659,
0.059523023664951324,
0.007657746318727732,
0.0686512291431427,
0.019466107711195946,
-0.00017113414651248604,
-0.01599142700433731,
0.08444727957248688,
-0.01398855447769165,
0.11938280612230301,
-0.004512988030910492,
-0.031971607357263565,
0.02075031027197838,
-0.00... |
10,008,768 | Pre-exposure rabies immunization of man with suckling mouse brain vaccine. | [
0.005071509629487991,
0.0490369088947773,
0.007962171919643879,
-0.0063147288747131824,
-0.013490770012140274,
0.0008847675635479391,
0.09004495292901993,
0.010255369357764721,
-0.06373072415590286,
0.11834783107042313,
-0.02468028850853443,
0.017543572932481766,
-0.026540666818618774,
0.0... |
10,008,769 | A case series study is reported which included serologic results obtained in 195 persons recruited from personnel and trainees of the Pan American Zoonoses Center in Buenos Aires, Argentina, and workers from other institutions. The individuals were vaccinated with three doses of suckling mouse brain vaccine administere... | [
0.04434042051434517,
0.01886320859193802,
0.04625280201435089,
-0.04826035350561142,
-0.02235146053135395,
-0.006492416374385357,
0.08906542509794235,
0.04333791509270668,
-0.03547588735818863,
0.06263002008199692,
0.03720909729599953,
0.030147219076752663,
0.0009381272830069065,
0.1086711... |
10,008,770 | International transeconomic trends of arterial diseases in the mid-1970s. | [
0.07005593180656433,
0.0007314266404137015,
-0.026591449975967407,
0.03428453952074051,
0.005422285292297602,
0.0038415747694671154,
-0.10391335189342499,
0.06313341856002808,
-0.04573780298233032,
0.05554775521159172,
-0.038706906139850616,
0.029988320544362068,
-0.07099300622940063,
0.07... |
10,008,771 | In developing countries, a positive linear dependence was found in the relationship between annual mortality from arterial diseases around 1975 and per capita gross national product (GNP). This dependence tends to increase with age. In industrialized countries, negative linear dependence was found for all age groups of... | [
0.04436562955379486,
-0.039114274084568024,
0.00470769265666604,
0.01272378396242857,
0.03343487158417702,
0.013139883056282997,
-0.06872355192899704,
0.005693620070815086,
-0.0472012534737587,
0.05356490612030029,
0.0909305065870285,
0.027501557022333145,
-0.023223763331770897,
0.03224002... |
10,008,772 | Increase of ABH nonsecretor among relatives of COPD patients. | [
-0.011417507193982601,
-0.01274888962507248,
-0.07174038141965866,
0.009206286631524563,
-0.04094606637954712,
0.01582854986190796,
0.061974335461854935,
0.07931312173604965,
-0.023096026852726936,
-0.03939749300479889,
0.07007201761007309,
-0.020442448556423187,
-0.0025737734977155924,
0.... |
10,008,773 | "Elimination of 'lead time' bias in assessing the effect of early breast cancer diagnosis". | [
0.04628148674964905,
0.021428992971777916,
-0.012339352630078793,
0.04181365296244621,
0.13233543932437897,
0.024084467440843582,
-0.06865624338388443,
0.030419861897826195,
0.00433029979467392,
-0.024616815149784088,
-0.029551949352025986,
0.021406715735793114,
-0.04901326447725296,
0.003... |
10,008,774 | Obtaining investigational drug information rapidly. | [
0.021868590265512466,
0.03747715801000595,
-0.059656981378793716,
-0.02752792462706566,
0.018770111724734306,
-0.013765711337327957,
-0.013289804570376873,
0.11075709760189056,
0.05059674382209778,
-0.0064030480571091175,
-0.028642375022172928,
0.07371071726083755,
-0.01950930617749691,
0.... |
10,008,775 | PVC gloves for handling antineoplastics. | [
-0.04349727928638458,
0.044807322323322296,
0.05631405860185623,
-0.00707944855093956,
0.0177741851657629,
-0.06247489154338837,
0.12368389219045639,
0.09139445424079895,
-0.012846776284277439,
0.02724429965019226,
0.022327471524477005,
0.0620470754802227,
0.013733701780438423,
0.058891240... |
10,008,776 | Theophylline--furosemide interaction? | [
0.056111469864845276,
-0.031707800924777985,
-0.04148437827825546,
0.008949073031544685,
0.04188159480690956,
0.00028243675478734076,
0.051440946757793427,
0.13997717201709747,
0.06812382489442825,
0.014817021787166595,
0.031053176149725914,
0.0498470813035965,
-0.039348676800727844,
0.065... |
10,008,777 | Guidelines for rapid attainment of therapeutic serum theophylline concentrations. | [
0.07421067357063293,
-0.017469320446252823,
0.016513168811798096,
-0.02023700810968876,
0.09091944992542267,
0.06915190070867538,
0.03742830082774162,
0.19456546008586884,
0.04737003147602081,
-0.019667629152536392,
-0.016285035759210587,
0.03263988345861435,
-0.027097737416625023,
0.16553... |
10,008,778 | Pseudopharmacy practice and the future. | [
-0.037558045238256454,
-0.010093005374073982,
-0.04533657431602478,
-0.015553604811429977,
-0.015653260052204132,
0.03965844586491585,
0.046916503459215164,
0.12720489501953125,
0.02252640388906002,
0.0006581428460776806,
-0.023347515612840652,
0.1057862862944603,
-0.04140821471810341,
0.0... |
10,008,779 | From the perspective of a researcher, the practice of hospital pharmacy is observed and future trends are discussed. Society is changing rapidly, and hospital pharmacy must seek innovative responses. In the past, hospital pharmacy has sometimes responded with pseudopharmacy--a term coined for paying lip service to impl... | [
-0.05106300488114357,
0.01195652037858963,
-0.027223611250519753,
-0.092778280377388,
-0.1127600148320198,
0.02125392109155655,
0.0714244395494461,
0.11546312272548676,
0.03284353390336037,
-0.032540928572416306,
-0.0440002866089344,
0.05363905429840088,
0.05008235201239586,
0.012134631164... |
10,008,780 | Review of nuclear pharmacy practice in hospitals. | [
0.014021117240190506,
0.051866065710783005,
-0.07009214162826538,
0.03470565006136894,
-0.09780430793762207,
0.014659573324024677,
-0.016811266541481018,
0.07768720388412476,
-0.0376330204308033,
-0.04550524801015854,
0.001706311828456819,
0.0924709364771843,
0.10085596144199371,
0.0396937... |
10,008,781 | An operational profile for nuclear pharmacy practice is presented, and the technical and professional role of nuclear pharmacists is reviewed. Key aspects of nuclear pharmacy practice in hospitals discussed are the basic facilities and equipment for the preparation, quality control, and distribution of radioactive drug... | [
0.009557250887155533,
0.02158461883664131,
-0.06871631741523743,
-0.005447508301585913,
-0.13398700952529907,
-0.020083418115973473,
0.04982484504580498,
0.11021116375923157,
-0.07734666019678116,
-0.01504544448107481,
-0.005707494914531708,
0.03165322169661522,
0.14396244287490845,
0.0284... |
10,008,782 | Job content and pharmacists' job attitudes. | [
-0.038517504930496216,
0.03127703070640564,
-0.03996112570166588,
-0.04965994134545326,
-0.024123234674334526,
-0.01429962832480669,
0.08593431115150452,
0.07194942235946655,
-0.04807301610708237,
-0.06211446225643158,
-0.04718790948390961,
0.06592102348804474,
-0.0130848977714777,
0.04013... |
10,008,783 | The relationships between job content and hospital pharmacists' work attitudes are examined. A 152-item questionnaire was mailed to 507 hospital pharmacists in southeastern Michigan. The questionnaire included measures of job dimensions, psychological states, and personal and work outcomes. Mean scores for 34 subscales... | [
0.007685759104788303,
0.02925886958837509,
-0.014036085456609726,
-0.025150930508971214,
-0.0518314465880394,
0.0019929625559598207,
0.03347403183579445,
0.07977408170700073,
0.026406992226839066,
-0.07673843950033188,
-0.06891472637653351,
-0.003147030947729945,
-0.01651667058467865,
0.03... |
10,008,784 | Antibiotic use review in ambulatory care using computer-assisted medical record audit. | [
-0.036564603447914124,
0.08467564731836319,
-0.04975184425711632,
-0.03485947847366333,
-0.03019675426185131,
0.019530905410647392,
-0.004470783285796642,
0.0863255187869072,
0.03694041073322296,
-0.03205187991261482,
-0.020223982632160187,
0.041096270084381104,
0.07997538894414902,
0.0718... |
10,008,785 | The use of a computer-assisted medical record audit (CAMRA) for reviewing antibiotic use in ambulatory patients was evaluated. A random sample of 40 medical records documenting treatment of streptococcal pharyngitis, otitis media, or acute, uncomplicated urinary tract infections at two family practice clinics was used ... | [
-0.0017214617691934109,
0.044719357043504715,
-0.11534131318330765,
-0.028728151693940163,
-0.08616200089454651,
0.013361632823944092,
-0.001694130478426814,
0.11761641502380371,
0.01895565539598465,
-0.021001417189836502,
-0.024764589965343475,
0.03324633836746216,
0.07013122737407684,
0.... |
10,008,786 | Pharmacist-managed allergy desensitization program. | [
0.030321884900331497,
0.01998548023402691,
0.04141794145107269,
-0.025453228503465652,
0.01551082730293274,
0.011328866705298424,
0.06625862419605255,
0.07162664830684662,
-0.0988214910030365,
0.011515077203512192,
-0.00861015822738409,
-0.01030223723500967,
0.027788134291768074,
0.0285573... |
10,008,787 | A pharmacist-managed immunotherapy program for ambulatory atopic patients is described. Pharmacists in a network of three health centers recommended that they assume management of the allergy desensitization program when they recognized problems with the existing program. Guidelines for the immunotherapy service were d... | [
0.017688672989606857,
0.045753542333841324,
0.05155929923057556,
0.002194898435845971,
0.005648738704621792,
-0.022937504574656487,
0.0844617635011673,
0.14499148726463318,
-0.030980482697486877,
0.024701178073883057,
-0.012914305552840233,
-0.04538805037736893,
0.061747413128614426,
0.047... |
10,008,788 | Hiring drug information personnel. | [
0.031421735882759094,
0.02287149243056774,
-0.0010543182725086808,
-0.036135632544755936,
-0.06255527585744858,
-0.009971470572054386,
0.034656912088394165,
0.058517538011074066,
-0.006719081196933985,
-0.05485772341489792,
-0.06142600625753403,
0.027577340602874756,
-0.0286279134452343,
0... |
10,008,789 | An analysis of the functions performed at a drug information center (DIC) is described as the basis for hiring personnel. A functional job analysis demonstrated a division in the duties of DIC personnel. The workload demanded a drug literature specialist (DLS) to access, store, and retrieve drug information, and a prac... | [
-0.020948391407728195,
0.03248710185289383,
-0.0023801287170499563,
-0.08889603614807129,
-0.08124176412820816,
-0.005733389873057604,
0.059567444026470184,
0.1301412731409073,
0.012273247353732586,
0.009128006175160408,
-0.10876447707414627,
0.08971979469060898,
-0.005264244973659515,
0.0... |
10,008,790 | Stability of haloperidol in 5% dextrose injection. | [
0.06497466564178467,
-0.148354634642601,
-0.024045417085289955,
0.010303357616066933,
0.009185481816530228,
0.008383573964238167,
-0.04278392344713211,
0.08894195407629013,
0.014581752009689808,
-0.051889799535274506,
-0.028647281229496002,
0.04199337214231491,
-0.017182420939207077,
0.040... |
10,008,791 | The stability of haloperidol in 5% dextrose injection using a high-pressure liquid chromatographic (HPLC) method is reported. A solution of haloperidol 10 mg/dl in 5% dextrose injection was prepared using commercially available haloperidol injection. The solution was stored at 24 degrees C, half in an amber glass bottl... | [
0.04783220216631889,
-0.11702744662761688,
-0.02771911397576332,
-0.001984817674383521,
0.01695537380874157,
0.02536579966545105,
-0.02335665188729763,
0.09206094592809677,
0.015393116511404514,
-0.06258644908666611,
0.006958330981433392,
0.006308374926447868,
0.012608574703335762,
0.05178... |
10,008,792 | Stability of some bronchodilator solutions during ultrasonic nebulization. | [
0.06446810811758041,
-0.13127656280994415,
0.0069908639416098595,
-0.03313547372817993,
-0.07050010561943054,
-0.01087956689298153,
-0.038942839950323105,
0.043850623071193695,
-0.07297612726688385,
-0.09179694205522537,
0.056856051087379456,
0.025521574541926384,
0.034715596586465836,
0.0... |
10,008,793 | The effect of ultrasonic nebulization on the stability of isoetharine hydrochloride and isoproterenol hydrochloride solutions was studied. Commercially available solutions of isoetharine hydrochloride 1%, isoproterenol hydrochloride 1%, and isoproterenol hydrochloride 0.5% were diluted to 0.25%, 0.125%, and 0.125%, res... | [
0.05730743333697319,
-0.12543140351772308,
0.017691168934106827,
-0.0418398417532444,
-0.015269358642399311,
0.0031478602904826403,
-0.02581445686519146,
0.10005897283554077,
-0.0132341543212533,
-0.1257701814174652,
0.039578698575496674,
-0.0025209086015820503,
0.032106224447488785,
0.036... |
10,008,794 | In vitro evaluation of liquid antacid products. | [
-0.003350618528202176,
-0.04065094515681267,
-0.06912838667631149,
-0.007958323694765568,
-0.01927325688302517,
0.02724553644657135,
0.06235809996724129,
0.10343999415636063,
-0.03137090057134628,
0.012626723386347294,
0.01627030223608017,
0.017349276691675186,
-0.049258988350629807,
0.084... |
10,008,795 | The in vitro neutralizing capacities, sodium content, and cost of 21 nonprescription antacid products were compared. A 5-ml sample of each antacid product was placed in a beaker using a pipette. The pipette was rinsed three times wtih purified water 5 ml, and the mixture was stirred with a magnetic stirring rod. After ... | [
0.01346319168806076,
-0.04873346909880638,
-0.0066991932690143585,
-0.029076317325234413,
-0.005991473328322172,
0.0055730040185153484,
0.04707001894712448,
0.09303987771272659,
-0.03970123827457428,
-0.016713721677660942,
-0.016941573470830917,
-0.011667541228234768,
0.029415970668196678,
... |
10,008,796 | Computerization needs assessment. | [
0.0007639346877112985,
0.029640071094036102,
-0.0673038512468338,
-0.06864332407712936,
-0.04265325143933296,
-0.053615160286426544,
0.03336223587393761,
0.02704254537820816,
-0.0871431902050972,
0.00954702403396368,
-0.05268886312842369,
-0.01623968780040741,
0.00016022953786887228,
0.008... |
10,008,797 | The process of assessing needs for a computer application in a hospital pharmacy is described. The variables discussed for which data are needed include hospital-specific characteristics, personnel, data storage, data retrieval, data transmission interfaces, and hardware. By determining these needs, the buyer will be a... | [
0.0021749939769506454,
0.06967272609472275,
-0.03506357595324516,
-0.12116985023021698,
-0.10135072469711304,
-0.003218097612261772,
0.044300924986600876,
0.13186019659042358,
-0.0022760045249015093,
-0.049237869679927826,
-0.05040708929300308,
-0.0333242304623127,
0.0849345326423645,
-0.0... |
10,008,798 | Bacterial contamination of aerosol solutions used to treat cystic fibrosis. | [
0.025177305564284325,
-0.055299192667007446,
0.05431917682290077,
0.020125098526477814,
0.07974554598331451,
0.0008639766019769013,
0.08976170420646667,
0.11196853220462799,
-0.009573518298566341,
-0.01648673787713051,
0.037904560565948486,
0.03565678745508194,
0.041730768978595734,
0.1375... |
10,008,799 | Stability of disopyramide phosphate in cherry syrup. | [
0.022606955841183662,
-0.12080924957990646,
-0.02745470032095909,
-0.10615308582782745,
-0.04255520552396774,
-0.003424127586185932,
0.040951162576675415,
0.06337903439998627,
-0.0392938069999218,
0.005642807576805353,
-0.009365750476717949,
0.13248033821582794,
-0.0627000704407692,
-0.034... |
10,008,800 | Use review of cimetidine injection. | [
0.035227108746767044,
-0.03513359650969505,
-0.045771293342113495,
-0.010632025077939034,
-0.1055130660533905,
-0.029291043058037758,
-0.04147470369935036,
0.13309670984745026,
-0.012791872024536133,
-0.06226130947470665,
0.027944575995206833,
0.004836675710976124,
0.012788072228431702,
0.... |
10,008,801 | Cost containment of emergency room prescriptions. | [
0.003349898150190711,
0.09574659913778305,
0.013334492221474648,
-0.017921077087521553,
0.045290492475032806,
0.009230389259755611,
0.04254024103283882,
0.06745273619890213,
0.06186041235923767,
-0.0014713967684656382,
-0.00650397501885891,
0.03579314798116684,
0.05057937279343605,
0.01441... |
10,008,802 | Marketing drug information to corporations. | [
0.027057992294430733,
0.0014665318885818124,
-0.05929293483495712,
-0.04152267798781395,
0.0006701174424961209,
0.028078202158212662,
0.06485603749752045,
0.0985422432422638,
0.031659673899412155,
-0.06342517584562302,
-0.022441545501351357,
0.09750006347894669,
0.003373932559043169,
-0.01... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.